Disclosure of Relevant Financial Relationships

The staff in the Office of Continuing Medical and Inter-Professional Education at Penn Medicine and the listed Planning Committee members (*) for this activity have disclosed that they have no financial relationships with any ineligible companies related to the content of this educational activity. In accordance with ACCME Standards, all individuals in control of content are required to disclose any financial relationships with ineligible companies that occurred within the past 24 months, regardless of whether the relationship is ongoing or has ended.

The following faculty and Planning Committee Members (*) have disclosed that they have no financial relationships with any ineligible companies related to the content of this educational activity.

Parul Agarwal, MD

Trinity Bivalacqua, MD, PhD

Sophia Borrelli

Jacqueline Cappadocia, MS, CGC

Emily Chu, MD, PhD

Elizabeth Clement, MD

Lauren Cuff, BS

Jessica Ebrahimzadeh, MS, CGC

Stefan M. Gysler, MD, MHS

Jordan Heiman, BS

Yasmin Kamal, MD, PhD

Daniel Lee, MD, MS

Jessica M. Long, MS, CGC*

Derek Mann, MS, CGC

Stacy Panchella, CRNP*

Erica Pettke, MD, MPH

Shira Rosenberg, MSc

Sydney Shaffer, MD, PhD

Derek Wong, PhD

The following faculty and Planning Committee member(s)* have disclosed all financial relationships with ineligible companies. All relevant financial relationships with ineligible companies are listed below. All relevant financial relationships have been mitigated.

Nina Bhardwaj, MD, PhD

Stock options in any amount of a publicly traded or privately owned (non-publicly traded) company-BreakBio|Other: Serving as Advisor/Board Member; Stock Option-Genotwin|Other: Serving as Advisor/Board Member; Stock Option-DC Prime|Other: Serving as Advisor/Board Member/Equity-Cell BioEngines|Other: Hold Stocks-Barinthus|Other: Consultant / Grant Recipient-Merck & Co|Other: Receipt of drug product-Oncovir|Other: Scientific Advisory Board, Stock options-Aikium|Other: Scientific Advisory Board-Epitopea|Grant or research support-Parker Institute Cancer Immunotherapy. |Grant or research support-NCI|Grant or research support-CRI

Sarah Coughlin, MD

Honoraria-Invitae (Relationship has ended) - 08/14/2025PDF

Bryson W. Katona, MD, PhD*

Grant or research support-Epigenomics (Relationship has ended)|Grant or research support-Janssen Pharmaceuticals (J&J) (Relationship has ended)|Advisor-Immunovia|Grant or research support-Guardant|Grant or research support-Freenome (Relationship has ended)|Grant or research support-Universal Diagnostics|Grant or research support-Recursion|Advisor-Parabilis|Speakers Bureau-Exact Sciences (Relationship has ended)

Emily Ko, MD, MSCR

Grant or research support-Faeth (Relationship has ended)|Grant or research support-Tesaro (Relationship has ended)|Grant or research support-Glaxo Smith Kline|Grant or research support-Bristol-Myers Squibb

Michael L. Kochman, MD

Consulting Fee-Olympus|Consulting Fee-Motive.MI|Advisor-Dark Canyon Labs|Stocks or stock options, excluding diversified mutual funds of a privately held company-Virgo|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Applied Clinical Intelligence|Stocks or stock options, excluding diversified mutual funds of a privately held company-Endosound|Advisor-AGA-Varia GI Opportunity Fund|Advisor-Varia|Stocks or stock options, excluding diversified mutual funds of a privately held company-Endiatx|Consulting Fee-Cook Medical|Grant or research support-Boston Scientific Corporation

Payal D. Shah, MD

Advisor-Astra Zeneca Pharmaceuticals|Advisor-Daiichi Sankyo (Relationship has ended)|Advisor-Gilead Sciences, Inc|Advisor-Biotheranostics (Relationship has ended)

E. John Wherry, PhD*